Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Dried Blood SPOT Analysis of Everolimus in Cancer Patients

NCT02809404 is registered in ClinicalTrials.gov with Radboud University Medical Center as lead sponsor.

NCT NCT02809404
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02809404 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Dried Blood SPOT Analysis of Everolimus in Cancer Patients
Lead sponsor
Radboud University Medical Center
Phase
Observational
Overall status
Completed
Start date
June 30, 2015
Completion date
January 31, 2017
Enrollment
75 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, renal cell carcinoma